Form 4 Tracker
Metagenomi Therapeutics, Inc.
MGX

17 insider filings · Latest: Sep 9, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 9, 2026Sep 11 11:51 PMLaurence ReidDirector
Purchase
20,000$1.17$23.4K20,000(D)

View →

Sep 8, 2026Sep 10 7:47 PMMatthew WeinTitle: General Counsel, Compliance Officer and Corporate Secretary
Sale
358$1.16$415126,133(D)

View →

Sep 8, 2026Sep 10 7:40 PMJian IrishDirector, President and Chief Executive Officer
Sale
2,140$1.16$2.5K375,393(D)

View →

Sep 8, 2026Sep 10 7:34 PMPamela WapnickChief Financial Officer
Sale
1,911$1.16$2.2K206,580(D)

View →

Jun 5, 2026Jun 10 3:23 PMPamela WapnickChief Financial Officer
Sale
2,884$1.30$3.7K208,491(D)

View →

Jun 5, 2026Jun 10 3:21 PMJian IrishDirector, President and Chief Executive Officer
Sale
3,737$1.30$4.9K377,533(D)

View →

Jun 5, 2026Jun 10 3:19 PMMatthew WeinTitle: General Counsel, Compliance Officer and Corporate Secretary
Sale
558$1.30$725126,491(D)

View →

Mar 5, 2026Mar 9 9:16 PMPamela WapnickChief Financial Officer
Sale
1,581$1.60$2.5K187,375(D)

View →

Mar 5, 2026Mar 9 9:16 PMMatthew WeinTitle: General Counsel, Compliance Officer and Corporate Secretary
Sale
482$1.60$771114,549(D)

View →

Mar 5, 2026Mar 9 9:15 PMJian IrishDirector, Chief Executive Officer
Sale
1,607$1.60$2.6K333,770(D)

View →

Sep 11, 2025Sep 11 8:25 PMNoonberg Sarah B.
Proposed Sale
35,832$1.90$68.1K—

View →

Jul 9, 2025Jul 9 10:34 PMSebastian Bernales
Proposed Sale
769,845$1.91$1.5M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 9, 2026Jun 11 6:31 PMLaurence ReidDirector
Grant/Award
17,400$1.2317,400(D)

View →

Jun 9, 2026Jun 11 6:23 PMWillard H DereDirector
Grant/Award
21,000$1.2321,000(D)

View →

Jun 9, 2026Jun 11 5:49 PMEric BjerkholtDirector
Grant/Award
21,000$1.2321,000(D)

View →

Jun 9, 2026Jun 11 5:37 PMJuergen EckhardtDirector
Grant/Award
21,000$1.2321,000(D)

View →

Apr 1, 2026Apr 3 6:11 PMJian IrishDirector, Title: President and Chief Executive Officer
Grant/Award
276,000$1.34276,000(D)

View →

Apr 1, 2026Apr 3 6:00 PMMatthew WeinTitle: General Counsel, Compliance Officer and Corporate Secretary
Grant/Award
68,000$1.3468,000(D)

View →

Apr 1, 2026Apr 3 5:40 PMPamela WapnickChief Financial Officer
Grant/Award
144,000$1.34144,000(D)

View →